Vertex Pharmaceuticals (Ondo Tokenized) (VRTXON): issuer, networks, and where it trades

VRTXON is a tokenized stock representing a structured note issued by Ondo Global Markets (BVI) Limited, a bankruptcy-remote special purpose vehicle operating under Swiss law. This instrument tracks Vertex Pharmaceuticals (VRTX) by providing synthetic exposure through a structured note, which offers holders redemption rights and a first-priority security interest in the collateral, rather than direct ownership of the underlying shares. Holders of VRTXON do not enjoy shareholder rights typically associated with direct stock ownership, such as voting rights or direct participation in dividends and stock splits; the specifics regarding how these corporate actions are managed for this instrument remain unclear. Additionally, VRTXON is distributed under Regulation S, meaning it is restricted to non-U.S. persons and requires KYC and wallet screening for compliance. The instrument exists on a blockchain network, though the specific network details are not provided in the legal substance.

VRTXON data covers 1 venues. The available products determine which staking rates, withdrawal fees and funding rates appear. Sources include exchange APIs, protocols and aggregators. Scheduled collection: exchange staking every 10 minutes, funding every 10 minutes, fees and network availability every 30 minutes. On-chain yields follow their source schedule.